A 2026 informational consumer report on MemoryON's cognitive health formula, Bacopa Monnieri and Phosphatidylserine dosage ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

When it comes to switching up an antidepressant, “there is a terrible lack of guidelines” to help doctors and patients make ...

In a new book, the conservative pundit Arthur C. Brooks offers tips to “young strivers” on maximizing their daily meaning ...

The way to a person’s brain is through their stomach. That’s the conclusion of a growing body of scientific studies that look ...

You’ve probably heard someone say exercise is “good for your head.” And you’ve probably nodded, filed it under vaguely true ...

A growing body of research shows that the stress and habits tied to sleeplessness can make it harder to rest the next night.

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

For decades, one of the greatest challenges to treating neurological disorders like attention-deficit/hyperactivity disorder is that its symptoms often resemble those of several other conditions.

Major depressive disorder, often called MDD, is one of the most serious and common mental health conditions in the world.

In today's The Daily Why, a new series from India Today Science, we try to understand the mechanism that triggers dreams, and the one that makes us forget them.